Andere talen Alligator Bioscience AB Deutsche Boerse AG

Aandelen

7AL

SE0000767188

Beurs gesloten - Deutsche Boerse AG Andere beurzen 14:22:04 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,093 ^EUR	+18,62%		+19,54%	+64,31%

23/05	Alligator Bioscience presenteert positieve fase 2-gegevens over mitazalimab bij alvleesklierkanker op de jaarlijkse ASCO-bijeenkomst in 2024	CI
21/05	US FDA geeft goedkeuring voor onderzoek naar een nieuw geneesmiddel voor Alligator Bioscience's proef met maagkankerbehandeling in een laat stadium	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting	23/05
US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial	21/05
Alligator Bioscience Announces Initiation of an Investigator-Initiated Phase 1 Clinical Study of Mitazalimab in Local Advanced Pancreatic Cancer	14/05
Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024	06/05
Alligator Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
Alligator Bioscience and Orion Corporation Announces Exercise of Development Option Under 2021 Research Collaboration and License Agreement	26/04
Alligator Bioscience AB Announces Graham Dixon and Veronica Wallin Not Proposed for Re-Election on Board	05/04
Alligator Bioscience Announces Publication of a Scientific Article Featuring Its Novel Bispecific Antibody Format RUBY® in the Peer-Reviewed Journal mAbs	26/03
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07/03
Transcript : Alligator Bioscience AB, 2023 Earnings Call, Feb 09, 2024	09/02
Correction: Alligator Bioscience Seeks SEK151 Million Capital Raising, Enters SEK59 Million Bridge Loan	09/02
Alligator Bioscience Seeks SEK151 Capital Raising, Enters SEK59 Million Bridge Loan	09/02
Alligator Bioscience to Trim Workforce Amid Restructuring Program	08/02
Alligator Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
Alligator Bioscience Plans to Adjust Size of Organization with Reduction of Approximately 20% to 25% of Current Workforce	08/02
Transcript : Alligator Bioscience AB - Special Call	29/01
Alligator Bioscience Announces Positive Top-Line Results from the Optimize-1 Phase 2 Study of the Company's Lead Asset Mitazalimab in 1st Line Metastatic Pancreatic Cancer	29/01
Alligator Bioscience Secures US Patent for Cancer Treatment Antibody	16/01
Transcript : Alligator Bioscience AB - Analyst/Investor Day	01/12
Alligator Bioscience AB Appoints Bertil Brinck as Chairman of the Nomination Committee	06/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alligator Bioscience AB Deutsche Boerse AG

Aandelen

7AL

SE0000767188

Andere talen

Filters